Profile data is unavailable for this security.
About the company
Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
- Revenue in SEK (TTM)97.00m
- Net income in SEK-29.85m
- Incorporated1990
- Employees37.00
- LocationIntegrum ABGemenskapens gata 9MOELNDAL 431 53SwedenSWE
- Phone+46 317601060
- Fax+46 31155260
- Websitehttps://integrum.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortivus AB | 73.40m | -21.88m | 133.91m | 38.00 | -- | 6.09 | -- | 1.82 | -0.4318 | -0.4318 | 1.43 | 0.2527 | 1.09 | 7.14 | 10.99 | 1,931,632.00 | -32.45 | -13.20 | -61.44 | -23.30 | 40.33 | 42.36 | -29.80 | -11.43 | 0.8252 | -10.66 | 0.4656 | -- | -8.72 | -7.36 | 12.16 | -- | -- | -- |
| Bactiquant A/S | 11.79m | -18.68m | 140.88m | -- | -- | 9.66 | -- | 11.95 | -0.4696 | -0.4696 | 0.2966 | 0.2723 | 0.4656 | 2.69 | 15.14 | -- | -73.73 | -55.41 | -85.85 | -64.53 | -31.80 | -10.94 | -158.37 | -121.81 | 3.26 | -9.70 | 0.1926 | -- | -41.68 | -14.27 | -4.72 | -- | -- | -- |
| Observe Medical ASA | 15.90m | -117.24m | 142.17m | 4.00 | -- | 5.76 | -- | 8.94 | -26.57 | -26.57 | 3.29 | 0.1909 | 0.1118 | 2.87 | 8.29 | 3,350,800.00 | -82.38 | -42.22 | -205.00 | -64.14 | 6.24 | 30.17 | -737.14 | -327.97 | 0.1175 | -3.72 | 0.9572 | -- | -33.85 | 153.47 | -98.73 | -- | -2.97 | -- |
| Immunovia AB (publ) | 684.00k | -145.91m | 146.31m | 13.00 | -- | 2.26 | -- | 213.90 | -0.4037 | -0.4037 | 0.0017 | 0.0962 | 0.0113 | 732.25 | 35.08 | 52,615.38 | -240.68 | -65.80 | -355.49 | -73.17 | -6,269.74 | -6,349.71 | -21,332.75 | -16,524.19 | 3.42 | -1.23 | 0.0131 | -- | -26.42 | 13.60 | -90.64 | -- | -34.89 | -- |
| iZafe Group AB | 5.99m | -16.68m | 162.75m | 10.00 | -- | 13.95 | -- | 27.17 | -0.0497 | -0.0497 | 0.0178 | 0.0315 | 0.2002 | 4.03 | 8.65 | 599,100.00 | -55.71 | -66.81 | -91.50 | -83.32 | -74.75 | -303.52 | -278.35 | -762.55 | 0.47 | -2,397.57 | 0.0054 | -- | -24.68 | -7.62 | 18.69 | -- | -- | -- |
| Subgen AI AB | 0.00 | -64.18m | 166.22m | 15.00 | -- | -- | -- | -- | -544.10 | -544.10 | 0.00 | -25.11 | 0.00 | -- | -- | 0.00 | -188.83 | -- | -403.12 | -- | -- | -- | -- | -- | -- | -4.46 | -- | -- | -100.00 | -- | 16.86 | -- | -- | -- |
| Boule Diagnostics AB | 489.60m | -3.50m | 166.98m | 187.00 | -- | 0.9963 | 9.94 | 0.3411 | -0.10 | -0.10 | 12.63 | 4.32 | 0.9926 | 4.68 | 3.50 | 2,618,182.00 | -0.7096 | -7.78 | -1.35 | -11.85 | 43.65 | 43.53 | -0.7149 | -9.10 | 0.8039 | 2.96 | 0.5717 | -- | -12.31 | 4.11 | 98.72 | -- | -5.26 | -- |
| Kdventures AB | 1.67m | -193.86m | 177.38m | 8.00 | -- | 0.0856 | -- | 106.15 | -0.5849 | -0.5849 | 0.005 | 3.16 | 0.0015 | -- | 0.4858 | -- | -16.82 | -1.95 | -16.98 | -2.03 | -- | -- | -11,601.14 | -1,139.53 | -- | -0.7754 | 0.0011 | -- | -9.09 | -8.82 | -2,292.98 | -- | -- | -- |
| Micropos Medical AB (publ) | 8.08m | -21.73m | 182.32m | 9.00 | -- | -- | -- | 22.57 | -0.1398 | -0.1398 | 0.0514 | -- | -- | -- | -- | -- | -- | -83.62 | -- | -110.96 | 120.03 | 94.59 | -268.99 | -558.00 | -- | -99.12 | -- | -- | 112.49 | 17.01 | 0.7589 | -- | -16.83 | -- |
| Clinical Laserthermia Systems AB | 17.49m | -41.61m | 186.67m | 16.00 | -- | 2.68 | -- | 10.67 | -1.55 | -1.55 | 0.6504 | 2.24 | 0.2256 | 2.61 | 4.86 | -- | -54.24 | -97.83 | -60.76 | -163.00 | -55.85 | -331.65 | -240.44 | -577.10 | 2.64 | -2.20 | 0.00 | -- | -6.90 | 67.36 | 12.62 | -- | 38.66 | -- |
| SciBase Holding AB (publ) | 36.58m | -90.39m | 207.09m | 34.00 | -- | 3.71 | -- | 5.66 | -0.2487 | -0.2487 | 0.0978 | 0.0674 | 0.6648 | 1.29 | 3.23 | 1,143,250.00 | -164.26 | -75.65 | -244.76 | -101.01 | 66.04 | 65.08 | -247.08 | -256.98 | 2.07 | -11.75 | 0.00 | -- | 27.79 | 26.21 | -9.97 | -- | -20.49 | -- |
| BrainCool AB (publ) | 36.21m | -37.05m | 216.00m | 17.00 | -- | 0.7884 | -- | 5.96 | -0.1427 | -0.1427 | 0.1395 | 0.6938 | 0.2044 | 1.03 | 1.37 | 2,130,235.00 | -20.91 | -33.76 | -23.03 | -42.19 | 26.29 | 40.37 | -102.31 | -179.58 | 4.88 | -8.62 | -- | -- | -9.38 | 38.79 | 15.88 | -- | -2.87 | -- |
| ContextVision AB | 110.22m | 761.60k | 220.06m | 43.00 | 276.29 | 2.39 | 28.21 | 2.00 | 0.0108 | 0.0108 | 1.53 | 1.25 | 0.8645 | 2.70 | 3.54 | 2,700,165.00 | 0.5974 | 22.42 | 0.7498 | 32.76 | 97.37 | 98.40 | 0.691 | 21.46 | 4.23 | -- | 0.1202 | -- | -15.61 | 3.08 | -96.81 | -53.90 | -13.09 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -35.57m | 220.18m | 21.00 | -- | 1.21 | -- | -- | -4.03 | -4.03 | 0.00 | 15.08 | 0.00 | -- | -- | 0.00 | -19.97 | -- | -24.07 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 80.11 | -- | -1.65 | -- |
| Integrum AB | 97.00m | -29.85m | 226.44m | 37.00 | -- | 1.20 | -- | 2.33 | -1.37 | -1.37 | 4.50 | 7.26 | 0.5253 | 0.828 | 3.40 | 2,487,052.00 | -16.17 | -3.58 | -17.87 | -4.08 | 75.61 | 83.88 | -30.78 | -6.47 | 1.88 | -- | 0.025 | -- | -12.50 | 27.78 | -864.22 | -- | 103.14 | -- |
| INIFY Laboratories AB | 20.14m | -61.42m | 307.97m | 34.00 | -- | 2.35 | -- | 15.29 | -1.13 | -1.13 | 0.3664 | 1.70 | 0.1928 | 2.96 | 3.12 | 848,737.60 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
Data as of Feb 27 2026. Currency figures normalised to Integrum AB's reporting currency: Swedish Krona SEK
0.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 2025 | 207.16k | 0.80% |
| Arvernus Capital AGas of 30 Sep 2025 | 29.23k | 0.11% |
| FCG Fonder ABas of 31 Mar 2025 | 3.50k | 0.01% |
| Rhenman & Partners Asset Management ABas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
